Telephone: 212.931.0704

In re Opana Antitrust Litigation, 14-cv-10151 (N.D. Ill.)

We represent plaintiffs and direct purchasers of Opana ER in this class action alleging that brand and generic drug companies entered into an unlawful agreement to delay generic competition in the market for extended release oxymorphone hydrochloride.  We are seeking to recover overcharges on behalf of the class of direct purchasers under the federal antitrust laws.

Reach Out

Taus, Cebulash & Landau, LLP • 80 Maiden Lane • Suite 1204 • New York, NY 10038 • T: 212.931.0704 • E: